+56.4% · 90d
$0.91
-0.03 (-3.51%)
News
(1)April 2026
Longeveron Files S-1 to Register 30.9 Million Shares for Resale
LGVNLongeveron Inc.
# 🧾 What This Document Is This is an **S-1 Registration Statement**. Think of it as a "permission slip" from the SEC. It doesn't mean Longeveron is selling new shares to raise money for itself right now. Instead, it's registering **30.9 million existing shares** so that certain investors (the "Sel
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%